Mako Co-Founder Takes Helm Of Therapeutic Ultrasound Firm
This article was originally published in Clinica
Executive Summary
Insightec, an Israeli company specializing in magnetic resonance-guided focused ultrasound (MRgFUS), has appointed its chairman, Maurice Ferré, as CEO. The move comes as the Haifa-based company secured $22m in new funds to ramp up commercialization of its US FDA-approved technology, which is designed for the noninvasive treatment of diseases and conditions in women’s health, oncology and neurology. Prior to joining Insightec, Ferré was co-founder, chairman and CEO of Mako Surgical, the robotic surgical company that was sold to Stryker in 2013. He replaces Kobi Vortman, Insightec’s founder, who will remain on the company’s board of directors.
You may also be interested in...
Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?
Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.
Roche Dx' EMEA Head To Take Charge After Diggelmann Departs
Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.
Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio
Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.